Kamal Hamed
0000-0003-1896-9736
Publication & Citation Trends
Publications
0 total
Randomized study of the efficacy, safety, and pharmacokinetics of SPR720 for the treatment of Mycobacterium avium complex pulmonary disease
Cited by 0
Semantic Scholar
P-1072. Evaluation of the Spontaneous Mutation Frequencies of SPR719 Alone and in Combination with Other Agents Used to Treat Mycobacterium avium Complex Pulmonary Disease OA
Cited by 0
Semantic Scholar
Evaluation of Factors Predictive of Efficacy Among Patients With Complicated Urinary Tract Infection and/or Acute Pyelonephritis
Cited by 1
Semantic Scholar
Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection
Cited by 11
Semantic Scholar
Serum Cell-Free DNA-based Detection of Mycobacterium avium Complex Infection OA
Cited by 14
Semantic Scholar
Intrapulmonary pharmacokinetics of SPR719 following oral administration of SPR720 to healthy volunteers OA
Cited by 2
Semantic Scholar
2130. Safety and Pharmacokinetics of SPR206 in Subjects with Varying Degrees of Renal Impairment OA
Cited by 3
Semantic Scholar
Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia.
Cited by 59
Semantic Scholar
Research Topics
Antimicrobial Resistance in Staphylococcus
(27)
Malaria Research and Control
(24)
Pneumonia and Respiratory Infections
(23)
Antibiotics Pharmacokinetics and Efficacy
(17)
Herpesvirus Infections and Treatments
(16)
Affiliations
Novartis (Switzerland)
Johns Hopkins University
University of Khartoum
Bayer (United States)
Mansoura University